Chinese A-shares closed sharply lower: Shanghai Composite -1.16%, Shenzhen Composite -4.52%, ChiNext -7.35%, STAR 50 -6.33%. Turnover CNY 2.03 trln, down CNY 50.8 bln vs prior session. More than 2,700 stocks fell. C Changxin recorded turnover >CNY 44 bln, down >4%, market cap CNY 3.14 trln. Brain‑computer interface names extended gains; Chuangxin Medical logged three limit-ups in four sessions, Seili Medical and Nanjing Panda posted two consecutive limit-ups. Lithography stocks active in the mor

2026-07-28

Chinese A-shares closed sharply lower: Shanghai Composite -1.16%, Shenzhen Composite -4.52%, ChiNext -7.35%, STAR 50 -6.33%. Turnover CNY 2.03 trln, down CNY 50.8 bln vs prior session. More than 2,700 stocks fell. C Changxin recorded turnover >CNY 44 bln, down >4%, market cap CNY 3.14 trln. Brain‑computer interface names extended gains; Chuangxin Medical logged three limit-ups in four sessions, Seili Medical and Nanjing Panda posted two consecutive limit-ups. Lithography stocks active in the morning—Zhangjiang Hi‑Tech, Bochang Optoelectronics, Yongxin Optical and Haili hit daily limits. Baijiu sector firmed, with Jinzhongzi Liquor at limit-up. AI hardware and related segments tumbled: CPO concept plunged—Cambridge Technology, Dongshan Precision and Guangxun Technology hit limit-downs; Xinyisheng, Yuanjie Technology and Zhongji Xuchuang fell more than 15%. Storage chip names were hit hardest: Xi’an Yicai hit a 20% limit-down, while GigaDevice, XinJieneng and Tongfu Microelectronics were among several stocks at limit-down.

其他消息
2026-07-28

The Hong Kong SAR government and China’s Ministry of Industry and Information Technology (MIIT) signed a cooperation agreement on 28 July at the SAR government headquarters to jointly establish a national manufacturing innovation center in Hong Kong. Hong Kong’s fiscal budget proposal has proposed reserving funds to build the first overseas national manufacturing innovation center, aimed at driving key technology breakthroughs, accelerating commercialization of results and attracting internation

2026-07-28

瑞銀分析師在一份報告中指出,微軟(MSFT.O)近期股價回調已爲第四財季業績釋放部分風險,下行空間相對有限。但其仍對微軟維持“買入”評級,同時將微軟目標價從510美元下調至480美元,理由是微軟可能會上調資本支出展望,同時維持而非上調Azure的增長指引——這種高支出疊加有限營收增長預期的組合,似乎不太受市場青睞。除資本支出和投資回報率討論外,微軟還可能面臨多方壓力:其對OpenAI的風險敞口、開源模型可能帶來的替代風險,以及其旗艦生產力軟件業務面臨的質疑。分析師寫道:“總而言之,我們維持‘買入’評級,但對此份財報持更爲平衡的態度。”